HSBC Holdings’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$478K Buy
98,127
+5,815
+6% +$34.1K ﹤0.01% 2291
2026
Q2
$445K Buy
92,312
+13,162
+17% +$79.4K ﹤0.01% 2336
2026
Q1
$473K Buy
+79,150
New +$657K ﹤0.01% 2245
2024
Q4
– Sell
-5,052
Closed -$245K – 3222
2024
Q3
$245K Buy
5,052
+1,020
+25% +$52.3K ﹤0.01% 2481
2024
Q2
$242K Buy
+4,032
New +$230K ﹤0.01% 2441

Other funds holding RXST

HSBC Holdings's RXST Position: Q3 2026 in Review

HSBC Holdings increased its RxSight (RXST) stake by 6.3% in Q3 2026, buying an estimated $34.1K and bringing the position to 98,127 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

HSBC Holdings first reported a position in RXST in Q2 2024 and has held it in 5 quarters since. 155 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • HSBC Holdings held 98,127 shares of RxSight worth $478K as of Q3 2026.
  • HSBC Holdings bought 5,815 RxSight shares in Q3 2026, an estimated $34.1K.
  • RxSight made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #2291 holding.
  • HSBC Holdings first reported a position in RxSight in Q2 2024 and has held it in 5 quarters since.
  • 155 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.